19874Toplam
50Olumlu
0Olumsuz
0Nötr
Sayfa 55 / 398 · toplam 19874 haber
▼
▲
Traws Pharma GAAP EPS of -$0.16 beats by $0.06
Bu özet yapay zekâ ile otomatik üretildi
Traws Pharma GAAP EPS of -$0.16 beats by $0.06
▼
▲
Jasper Therapeutics GAAP EPS of -$0.10 beats by $0.22
Bu özet yapay zekâ ile otomatik üretildi
Jasper Therapeutics GAAP EPS of -$0.10 beats by $0.22
▼
▲
Why is Geely Automobile stock rallying today?
Bu özet yapay zekâ ile otomatik üretildi
Why is Geely Automobile stock rallying today?
▼
▲
Sunshine Biopharma earnings beat by $0.05, revenue topped estimates
Bu özet yapay zekâ ile otomatik üretildi
Sunshine Biopharma earnings beat by $0.05, revenue topped estimates
▼
▲
Malaysia’s July CPI rises 1.8% y/y, slightly less than forecast
Bu özet yapay zekâ ile otomatik üretildi
Malaysia’s July CPI rises 1.8% y/y, slightly less than forecast
▼
▲
Xi Touts Party-Led Growth at Predecessor’s Birth Centenary - bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
Xi Touts Party-Led Growth at Predecessor’s Birth Centenary bloomberg.com
▼
▲
Copper Heads Toward Record High on LME as Supply Tensions Build - Bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
Copper Heads Toward Record High on LME as Supply Tensions Build Bloomberg.com
▼
▲
Fiducian FY 2026 slides: underlying profit up 15% despite penalty
Bu özet yapay zekâ ile otomatik üretildi
Fiducian FY 2026 slides: underlying profit up 15% despite penalty
▼
▲
Where Will Palantir Stock Be in 2030?
Bu özet yapay zekâ ile otomatik üretildi
Palantir's rapid growth could continue to lift the stock.
▼
▲
A Warner Bros. Discovery Director Sells Nearly 70% of Their Direct Stake Worth $2 Million as the Company's Paramount Skydance Merger Runs into Challenges
Bu özet yapay zekâ ile otomatik üretildi
The insider dumped a substantial portion of their direct holdings after the stock surged 130% over the past year.
▼
▲
Aurizon FY2026 slides: profit surges 24% despite coal headwinds
Bu özet yapay zekâ ile otomatik üretildi
Aurizon FY2026 slides: profit surges 24% despite coal headwinds
▼
▲
Earnings call transcript: Aurizon FY 2026 profit rises as stock falls 10%
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: Aurizon FY 2026 profit rises as stock falls 10%
▼
▲
Earnings call transcript: BlueScope posts strong H2 2026, stock slips 2.4%
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: BlueScope posts strong H2 2026, stock slips 2.4%
▼
▲
Earnings call transcript: New Hope Group posts strong FY 2026 cash flow
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: New Hope Group posts strong FY 2026 cash flow
▼
▲
Oil prices edge lower after strong week; Iran jitters persist
Bu özet yapay zekâ ile otomatik üretildi
Oil prices edge lower after strong week; Iran jitters persist
▼
▲
2 Stocks Down 15% and 30% to Buy Right Now and Hold for the Next Decade
Bu özet yapay zekâ ile otomatik üretildi
Two category leaders are still off their highs, yet continue to report double-digit revenue growth.
▼
▲
CXMT’s Rise to China’s Most Valuable Firm Heralds New Tech Era - Bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
CXMT’s Rise to China’s Most Valuable Firm Heralds New Tech Era Bloomberg.com
▼
▲
Earnings call transcript: Imdex posts record FY 2026, shares slip 2.6% on outlook
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: Imdex posts record FY 2026, shares slip 2.6% on outlook
▼
▲
After Being Left for Dead, These High-Yield Stocks Look to Rally Again. Here's How to Play It.
Bu özet yapay zekâ ile otomatik üretildi
After Being Left for Dead, These High-Yield Stocks Look to Rally Again. Here's How to Play It.
▼
▲
Audinate FY26 slides: 15% revenue growth, 82% margins maintained
Bu özet yapay zekâ ile otomatik üretildi
Audinate FY26 slides: 15% revenue growth, 82% margins maintained
▼
▲
BlueScope FY profit jumps over 100% on U.S., Asia strength
Bu özet yapay zekâ ile otomatik üretildi
BlueScope FY profit jumps over 100% on U.S., Asia strength
▼
▲
Earnings call transcript: GWA lifts profit in H2 2026 as stock rises
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: GWA lifts profit in H2 2026 as stock rises
▼
▲
Earnings call transcript: Audinate jumps 13% after FY 2026 return to growth
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: Audinate jumps 13% after FY 2026 return to growth
▼
▲
a2 Milk FY 2026 slides: revenue rises 12%, margins pressured
Bu özet yapay zekâ ile otomatik üretildi
a2 Milk FY 2026 slides: revenue rises 12%, margins pressured
▼
▲
oOh!media 1H26 slides: revenue rises but margins compress amid mix shift
Bu özet yapay zekâ ile otomatik üretildi
oOh!media 1H26 slides: revenue rises but margins compress amid mix shift
▼
▲
This Software Stock Just Produced a Rule of 40 Score Nearly as High as Palantir's, and Its Valuation Is Much More Attractive
Bu özet yapay zekâ ile otomatik üretildi
Despite rapid growth, shares of this AI-fueled software company are cheap.
▼
▲
Earnings call transcript: GPT Group posts solid H1 2026 growth, shares flat
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: GPT Group posts solid H1 2026 growth, shares flat
▼
▲
Earnings call transcript: Iress lifts profit outlook in H1 2026 as revenue slows
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: Iress lifts profit outlook in H1 2026 as revenue slows
▼
▲
Freightways FY26 slides: strong growth clouded by Q4 softening
Bu özet yapay zekâ ile otomatik üretildi
Freightways FY26 slides: strong growth clouded by Q4 softening
▼
▲
a2 Milk FY profit slumps 44% on China supply disruptions
Bu özet yapay zekâ ile otomatik üretildi
a2 Milk FY profit slumps 44% on China supply disruptions
▼
▲
In Retirement, More Spending Can Lead to Higher Taxes
Bu özet yapay zekâ ile otomatik üretildi
One extra withdrawal from your IRA can set off a chain reaction of higher taxes and even surprise Medicare surcharges — for years to come.
▼
▲
Earnings call transcript: Freightways posts strong H2 2026 results as fuel costs bite
Bu özet yapay zekâ ile otomatik üretildi
Earnings call transcript: Freightways posts strong H2 2026 results as fuel costs bite
▼
▲
WuXi AppTec’s 100% Stock Rally Defies Geopolitical Headwinds - Bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
WuXi AppTec’s 100% Stock Rally Defies Geopolitical Headwinds Bloomberg.com
▼
▲
A2 Milk profit tumbles 44% after China formula shortage
Bu özet yapay zekâ ile otomatik üretildi
A2 Milk profit tumbles 44% after China formula shortage
▼
▲
Tesla Stock Faces a High Stakes Reality Check After Its Record Quarter
Bu özet yapay zekâ ile otomatik üretildi
Tesla's record quarter looks impressive at first glance, but the numbers beneath it raise a much bigger question about the stock's future.
▼
▲
What BBB Foods' Long Growth Runway Means, and Why a Director's Latest Insider Transaction Doesn't Detract From It
Bu özet yapay zekâ ile otomatik üretildi
What BBB Foods' Long Growth Runway Means, and Why a Director's Latest Insider Transaction Doesn't Detract From It
▼
▲
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds
Bu özet yapay zekâ ile otomatik üretildi
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds
▼
▲
Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know
Bu özet yapay zekâ ile otomatik üretildi
Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know
▼
▲
U.S. air-conditioner shipments jump in June as H1 growth remains modest
Bu özet yapay zekâ ile otomatik üretildi
U.S. air-conditioner shipments jump in June as H1 growth remains modest
▼
▲
QuickLogic Targets Defense, Space Growth With Rad-Hard FPGA Push
Bu özet yapay zekâ ile otomatik üretildi
QuickLogic Targets Defense, Space Growth With Rad-Hard FPGA Push
▼
▲
Société Générale sees more room for KOSPI recovery despite rebuilding leverage
Bu özet yapay zekâ ile otomatik üretildi
Société Générale sees more room for KOSPI recovery despite rebuilding leverage
▼
▲
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
Bu özet yapay zekâ ile otomatik üretildi
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
▼
▲
Qualys Conference: ETM and Patch Management Drive Growth Ambitions
Bu özet yapay zekâ ile otomatik üretildi
Qualys Conference: ETM and Patch Management Drive Growth Ambitions
▼
▲
Nebius' Contracted Power Guidance Continues to Surge. Here's What That Means for the Stock.
Bu özet yapay zekâ ile otomatik üretildi
Nebius' Contracted Power Guidance Continues to Surge. Here's What That Means for the Stock.
▼
▲
Bending Spoons Beats on Earnings in Its Public Market Debut Quarter. Investors Focus on the Fine Print Instead
Bu özet yapay zekâ ile otomatik üretildi
Bending Spoons Beats on Earnings in Its Public Market Debut Quarter. Investors Focus on the Fine Print Instead
▼
▲
Oppenheimer Just Upgraded Intuitive Surgical Stock. Here's Why.
Bu özet yapay zekâ ile otomatik üretildi
Oppenheimer Just Upgraded Intuitive Surgical Stock. Here's Why.
▼
▲
OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
Bu özet yapay zekâ ile otomatik üretildi
OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
▼
▲
High Dividend ETFs Are Beating the S&P 500 by 9 Points in 2026 and These 3 Pay Up to 4 Percent While Doing It
Bu özet yapay zekâ ile otomatik üretildi
High Dividend ETFs Are Beating the S&P 500 by 9 Points in 2026 and These 3 Pay Up to 4 Percent While Doing It
▼
▲
Morgan Stanley Favours Quality, AI Adopters and Financials as Earnings Growth Broadens
Bu özet yapay zekâ ile otomatik üretildi
Morgan Stanley Favours Quality, AI Adopters and Financials as Earnings Growth Broadens
▼
▲
Applied Materials Trades More Than 25% Below Its High With Revenue at a Record
Bu özet yapay zekâ ile otomatik üretildi
The equipment maker just posted records on nearly every line and guided even higher.
Sayfa 55 / 398 · toplam 19874 haber
Yatırım tavsiyesi değildir. Bu sayfadaki Lothien sağlamlık skorları, DCF teorik değerler ve analizler yalnızca bilgilendirme amaçlıdır. Yatırım tavsiyesi niteliği taşımaz. SPK (Sermaye Piyasası Kurulu) düzenlemelerine tabidir. Yatırım kararlarınızı almadan önce lisanslı bir yatırım danışmanına başvurunuz. Geçmiş performans gelecekteki sonuçların garantisi değildir.